EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis

Shyam Sundar, Anup Singh, Anurag Tiwari, Saurabh Shukla, Jaya Chakravarty, Madhukar Rai

ISRN Parasitology · 2014

DOI: 10.1155/2014/548010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Parasitology, 2014. Verfasst von Shyam Sundar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-kala-azar dermal leishmaniasis (PKDL) plays an important role in maintaining endemicity of visceral leishmaniasis and its transmission. Treatment regimens for PKDL are toxic and require 3-4 months of hospitalization. These long and arduous regimens result in extensive noncompliance. There is an urgent need to develop a safe, effective, and acceptable regimen for the treatment of PKDL. Paromomycin (PM) has been recently approved in India for treatment of visceral leishmaniasis (VL); hence we tested its efficacy in patients with PKDL.

Methods

In this exploratory study, 31 patients with PKDL aged 10 years and above were administered PM 11 mg/kg daily intramuscularly for 45 days and followed up for one year.

Results

Out of 31 patients, 7 patients were lost to followup at 1 year and 9 (37.5%) got cured with complete disappearance of lesion, while 15 (62.5%) showed no improvement by per protocol analysis.

Conclusion

Cure rate with 45 intramuscular injections of PM was unacceptably low though there was no serious side effect of the drug. Whether paromomycin can be used in multidrug therapy to shorten the duration of treatment should be the next logical step for investigation.

Autor:innen und Institutionen

  • Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.

Zitieren

APA

Sundar, S., Singh, A., Tiwari, A., Shukla, S., Chakravarty, J., & Rai, M. (2014). Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis. ISRN Parasitology. https://doi.org/10.1155/2014/548010

Vancouver

Sundar S, Singh A, Tiwari A, Shukla S, Chakravarty J, Rai M. Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis. ISRN Parasitology. 2014. doi:10.1155/2014/548010

BibTeX
@article{Sundar2014,
  author = {Sundar, Shyam and Singh, Anup and Tiwari, Anurag and Shukla, Saurabh and Chakravarty, Jaya and Rai, Madhukar},
  title = {Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis},
  journal = {ISRN Parasitology},
  year = {2014},
  doi = {10.1155/2014/548010}
}
Kostenlos starten →